These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8051159)

  • 21. Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.
    Chekanov AV; Remacle AG; Golubkov VS; Akatov VS; Sikora S; Savinov AY; Fugere M; Day R; Rozanov DV; Strongin AY
    Arch Biochem Biophys; 2006 Feb; 446(1):52-9. PubMed ID: 16384550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel.
    Zhang S; Finkelstein A; Collier RJ
    Proc Natl Acad Sci U S A; 2004 Nov; 101(48):16756-61. PubMed ID: 15548616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthrax biosensor, protective antigen ion channel asymmetric blockade.
    Halverson KM; Panchal RG; Nguyen TL; Gussio R; Little SF; Misakian M; Bavari S; Kasianowicz JJ
    J Biol Chem; 2005 Oct; 280(40):34056-62. PubMed ID: 16087661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular assembly of lethal factor enzyme and pre-pore heptameric protective antigen in early stage of translocation.
    Alisaraie L; Rouiller I
    J Mol Model; 2016 Jan; 22(1):7. PubMed ID: 26659402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.
    Solano MI; Woolfitt AR; Boyer AE; Lins RC; Isbell K; Gallegos-Candela M; Moura H; Pierce CL; Barr JR
    Analyst; 2019 Mar; 144(7):2264-2274. PubMed ID: 30810119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin.
    Mogridge J; Mourez M; Collier RJ
    J Bacteriol; 2001 Mar; 183(6):2111-6. PubMed ID: 11222612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
    Moayeri M; Leysath CE; Tremblay JM; Vrentas C; Crown D; Leppla SH; Shoemaker CB
    J Biol Chem; 2015 Mar; 290(10):6584-95. PubMed ID: 25564615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
    Singh Y; Klimpel KR; Arora N; Sharma M; Leppla SH
    J Biol Chem; 1994 Nov; 269(46):29039-46. PubMed ID: 7961869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.
    Salles II; Voth DE; Ward SC; Averette KM; Tweten RK; Bradley KA; Ballard JD
    Cell Microbiol; 2006 Aug; 8(8):1272-81. PubMed ID: 16882031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxins of Bacillus anthracis.
    Brossier F; Mock M
    Toxicon; 2001 Nov; 39(11):1747-55. PubMed ID: 11595637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthrax edema factor, voltage-dependent binding to the protective antigen ion channel and comparison to LF binding.
    Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Benz R
    J Biol Chem; 2006 Oct; 281(43):32335-43. PubMed ID: 16954207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and interaction of PA63 and EF (edema toxin) of Bacillus anthracis with lipid membrane.
    Wang XM; Wattiez R; Mock M; Falmagne P; Ruysschaert JM; Cabiaux V
    Biochemistry; 1997 Dec; 36(48):14906-13. PubMed ID: 9398214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of N-terminal fragments of anthrax edema factor (EF(N)) and lethal factor (LF(N)) to the protective antigen pore.
    Leuber M; Kronhardt A; Tonello F; Dal Molin F; Benz R
    Biochim Biophys Acta; 2008 Jun; 1778(6):1436-43. PubMed ID: 18243126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus.
    Milne JC; Blanke SR; Hanna PC; Collier RJ
    Mol Microbiol; 1995 Feb; 15(4):661-6. PubMed ID: 7783638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
    Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
    J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
    Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
    Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GRP78(BiP) facilitates the cytosolic delivery of anthrax lethal factor (LF) in vivo and functions as an unfoldase in vitro.
    Tamayo AG; Slater L; Taylor-Parker J; Bharti A; Harrison R; Hung DT; Murphy JR
    Mol Microbiol; 2011 Sep; 81(5):1390-401. PubMed ID: 21797942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
    Gupta P; Singh A; Chauhan V; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designed azolopyridinium salts block protective antigen pores in vitro and protect cells from anthrax toxin.
    Beitzinger C; Bronnhuber A; Duscha K; Riedl Z; Huber-Lang M; Benz R; Hajós G; Barth H
    PLoS One; 2013; 8(6):e66099. PubMed ID: 23840407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
    Liu S; Leppla SH
    J Biol Chem; 2003 Feb; 278(7):5227-34. PubMed ID: 12468536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.